Interestingly, higher levels of CXCL10 have also been reported with other hepatotropic viruses such as hepatitis B virus (HBV) and HCV and it was suggested that this chemokine could be used as a biomarker predicting liver injury and phases of infection in the context of HBV and liver fibrosis in the context of HCV (54–56). The gene discussed is CXCL10; the disease is Hepatic fibrosis.